Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hyer

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Acta Endocrinologica|September 1, 1988
Failure to suppress GH secretion after 2 weeks treatment with atropine or propanthelene in diabetics with proliferative retinopathyS L Hyer, P S Sharp, R A Brooks, et al.
Journal of Consulting and Clinical Psychology|October 1, 1986
Inpatient diagnosis of posttraumatic stress disorderL Hyer, W C O'Leary, R T Saucer, et al.
Journal of Clinical Psychology|October 1, 1977
Demographic and clinical characteristics as predictors of length of hospitalization and readmissionP H Munley, N Devone, C M Einhorn, et al.
Cancer Gene Therapy|April 8, 2003
Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expressionMarc L Hyer, Sunil Sudarshan, David A Schwartz, et al.
Nuclear Medicine Communications|April 4, 2018
Dosimetry-based treatment for Graves' diseaseSteve L Hyer, Brenda Pratt, Matthew Gray, et al.
Current Gene Therapy|July 12, 2002
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancerJ S Norris, M L Hyer, C Voelkel-Johnson, et al.
Cancer Gene Therapy|October 30, 2004
In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancerSunil Sudarshan, David H Holman, Marc L Hyer, et al.
Cancer Research|April 17, 2008
Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancerMarc L Hyer, Ranxin Shi, Maryla Krajewska, et al.
Cancer Biology & Therapy|November 15, 2002
Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosisMarc L Hyer, Sunil Sudarshan, Youngsoo Kim, et al.
Journal of Personality Assessment|January 1, 1988
Vietnam veterans: overreporting versus acceptable reporting of symptomsL Hyer, P Boudewyns, W R Harrison, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Acta Endocrinologica|September 1, 1988
Failure to suppress GH secretion after 2 weeks treatment with atropine or propanthelene in diabetics with proliferative retinopathyS L Hyer, P S Sharp, R A Brooks, et al.
Journal of Consulting and Clinical Psychology|October 1, 1986
Inpatient diagnosis of posttraumatic stress disorderL Hyer, W C O'Leary, R T Saucer, et al.
Journal of Clinical Psychology|October 1, 1977
Demographic and clinical characteristics as predictors of length of hospitalization and readmissionP H Munley, N Devone, C M Einhorn, et al.
Cancer Gene Therapy|April 8, 2003
Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expressionMarc L Hyer, Sunil Sudarshan, David A Schwartz, et al.
Nuclear Medicine Communications|April 4, 2018
Dosimetry-based treatment for Graves' diseaseSteve L Hyer, Brenda Pratt, Matthew Gray, et al.
Current Gene Therapy|July 12, 2002
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancerJ S Norris, M L Hyer, C Voelkel-Johnson, et al.
Cancer Gene Therapy|October 30, 2004
In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancerSunil Sudarshan, David H Holman, Marc L Hyer, et al.
Cancer Research|April 17, 2008
Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancerMarc L Hyer, Ranxin Shi, Maryla Krajewska, et al.
Cancer Biology & Therapy|November 15, 2002
Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosisMarc L Hyer, Sunil Sudarshan, Youngsoo Kim, et al.
Journal of Personality Assessment|January 1, 1988
Vietnam veterans: overreporting versus acceptable reporting of symptomsL Hyer, P Boudewyns, W R Harrison, et al.
Pageof 11